Multinational medicines - Ensuring drug quality in an era of global manufacturing

New England Journal of Medicine

Volumn 361, Issue 8, 2009, Pages 737-740

  Okie, Susan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; DIGITEK; DIGOXIN; GENERIC DRUG; HEPARIN; METOPROLOL SUCCINATE; UNCLASSIFIED DRUG;

DRUG FATALITY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG SCREENING; DYSPNEA; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RHYTHM; HUMAN; HYPERTENSION; LUNG CONGESTION; PRIORITY JOURNAL; QUALITY CONTROL; SHELF LIFE; SHORT SURVEY; SIDE EFFECT; SINUS RHYTHM; TABLET;

EID: 69049110999     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0903870     Document Type: Article

References (2)

1. Drug safety: preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program. Washington, DC: Government Accountability Office, April 22, 2008. (Publication no. GAO-08-701T.) (Accessed July 30, 2009, at http://www.gao.gov/ new.items/d08701t.pdf.)
2. QuarterWatch: 2008 quarter 3. Alexandria, VA: The Institute for Safe Medication Practices, May 7, 2009. (Accessed July 30, 2009, at http://www.ismp.org/quarterwatch/2008Q3.pdf.)